Package 55111-575-03

{"route": ["ORAL"], "spl_id": "eeeb1802-6fe6-ebb0-2df8-98b42385b89f", "openfda": {"unii": ["J12U072QL0"], "rxcui": ["904932"], "spl_set_id": ["f94d9c49-245a-8081-42c4-785113fce498"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (55111-575-03)  / 1 TABLET in 1 BLISTER PACK (55111-575-11)", "package_ndc": "55111-575-03", "marketing_start_date": "20120621"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (55111-575-43)  / 3 TABLET in 1 BLISTER PACK (55111-575-13)", "package_ndc": "55111-575-43", "marketing_start_date": "20211120"}], "brand_name": "Ibandronate sodium", "product_id": "55111-575_eeeb1802-6fe6-ebb0-2df8-98b42385b89f", "dosage_form": "TABLET", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "55111-575", "generic_name": "Ibandronate sodium", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ibandronate sodium", "active_ingredients": [{"name": "IBANDRONATE SODIUM", "strength": "150 mg/1"}], "application_number": "ANDA078997", "marketing_category": "ANDA", "marketing_start_date": "20120621", "listing_expiration_date": "20261231"}